In this video, Sara Ana Cossa (study participant) and Leocádia Vilanculos (researcher at Centro de Investigação em Saúde de Manhiça) present the PROTECT study in Mozambique, reflecting on its goals and reasons for contributing to research on maternal vaccines.

A study conducted at the Manhiça Health Research Centre (CISM) identified a high prevalence of mutations associated with antiretroviral drug resistance among children living with HIV and their mothers, highlighting the importance of making drug resistance testing and treatment response monitoring more accessible, particularly in low-income settings.

The Director-General of the Manhiça Health Research Centre (CISM), Francisco Saúte, participated on 6 and 7 October 2026 in the General Assembly of the European and Developing Countries Clinical Trials Partnership (EDCTP), held in Brussels, Belgium. The meeting brought together representatives of participating countries and institutions to discuss strategic issues related to clinical research and funding priorities.

The meeting brought together researchers, healthcare professionals, representatives of national and international institutions, partners and students to discuss scientific advances and research priorities in tuberculosis in Mozambique. How can scientific research findings be translated into practical solutions to address the challenges posed by tuberculosis (TB) in Mozambique? This was one of the key questions guiding the discussions at the 2nd Annual Forum of the Manhiça TB

During the discussion, participants proposed the creation or strengthening of a working group dedicated to fungal diseases, bringing together the Ministry of Health, researchers, clinicians, laboratories and partners. Such a platform would allow for the regular review of results, discussion of gaps and development of proposals for the National Directorate of Public Health.

Three researchers from the Manhiça Health Research Centre (CISM) are members of The NUS–Lancet PRIME Commission on Pandemic Readiness, an international Commission established to rethink preparedness for future pandemics and contribute to policies and strategies capable of protecting communities more effectively and equitably, with particular attention to the most vulnerable groups.

Eight organisations established a new international consortium across Africa and Europe to strengthen access to tuberculosis (TB) preventive treatment. How? Through innovative testing, digital health solutions, and community-based care. The consortium TEST4TPT, collaborates to address one of the most persistent challenges in TB prevention to date: early identification of people exposed to TB and connecting them to preventive care.

In an interview with Radio France Internationale (RFI), Pedro Aide, researcher and coordinator of the Malaria Area at the Manhiça Health Research Centre (CISM), highlighted some of the main challenges that continue to hinder malaria control in Mozambique. Despite the progress achieved, the disease remains one of the leading causes of illness, hospitalisation and death in the country.

For those preparing to pursue a career in Medicine, direct exposure to clinical realities can profoundly transform the way they understand the profession. This was precisely the experience lived by a group of students from the University of Navarra, Spain, during an internship at the Manhiça Health Research Centre (CISM) and the Manhiça District Hospital (HDM). There, they had the opportunity to gain first-hand experience of health research, clinical practice and the challeng

Scheduled for late November, the Forum is expected to bring together health institutions, communication professionals and journalists, researchers, policymakers, civil society organisations, development partners, academia and the private sector, in a space for sharing experiences, reflecting on challenges and identifying solutions for more effective, accessible and people-centred health communication.